Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026)

Annexon's (ANNX) quarterly Depreciation & Amortization (CF) came in at $539000.0 in Q1 2026, little changed year-on-year from $537000.0 in Q1 2025, and down 0.74% quarter-over-quarter from $543000.0 in Q4 2025.

Annexon (ANNX) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Annexon's Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $539000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.37% year-over-year to $539000.0 in Q1 2026; TTM through Mar 2026 was $2.2 million, a 0.88% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 0.74% from the prior year.
  • Depreciation & Amortization (CF) fell to $539000.0 in Q1 2026 per ANNX's latest filing, from $543000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $546000.0 in Q3 2025 and bottomed at $518000.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $538000.0 (2023), against an average of $535823.5.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 4.74% in 2022; the steepest drop was 7.33% in 2022.
  • Year by year, Depreciation & Amortization (CF) stood at $530000.0 in 2022, then rose by 1.51% to $538000.0 in 2023, then fell by 0.19% to $537000.0 in 2024, then climbed by 1.12% to $543000.0 in 2025, then dropped by 0.74% to $539000.0 in 2026.
  • Per Business Quant, the three latest ANNX Depreciation & Amortization (CF) figures stand at $539000.0 (Q1 2026), $543000.0 (Q4 2025), and $546000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 41.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - 91,781.47
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Annexon 1.03 Bn 804.24 Mn - 539,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 539,000.00
Mar 31, 2026 539,000.00
Dec 31, 2025 543,000.00
Dec 31, 2025 543,000.00
Sep 30, 2025 546,000.00
Sep 30, 2025 546,000.00
Jun 30, 2025 540,000.00
Jun 30, 2025 540,000.00
Mar 31, 2025 537,000.00
Mar 31, 2025 537,000.00
Dec 31, 2024 537,000.00
Dec 31, 2024 537,000.00
Sep 30, 2024 538,000.00
Sep 30, 2024 538,000.00
Jun 30, 2024 537,000.00
Jun 30, 2024 537,000.00
Mar 31, 2024 538,000.00
Mar 31, 2024 538,000.00
Dec 31, 2023 538,000.00
Dec 31, 2023 538,000.00